Provided is a highly potent and selective endocannabioid cellular reuptake inhibitor represented by formula (I):
or a pharmaceutically acceptable solvate or co-crystal thereof as well as to a formulation comprising this inhibitor, and to methods of treatment in which this inhibitor is used.